Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Firebrick Pharma Limited ( (AU:FRE) ) has shared an update.
Firebrick Pharma Limited has called a virtual general meeting of shareholders for 22 June 2026, enabling investors to attend online via a platform powered by Automic, submit questions and vote, with eligibility determined as of 20 June 2026. The meeting underscores the company’s continued use of digital channels to engage shareholders while maintaining formal governance requirements.
Shareholders will be asked to ratify several prior securities issuances, including placement shares to Pharma Nutria N.A. Inc., incentive options to Al Moghaddam, and additional shares issued in an April 2026 placement under ASX Listing Rules 7.1 and 7.1A. Approval of these ratifications would refresh the company’s placement capacity under ASX rules, providing Firebrick Pharma with greater flexibility for future capital raising and potentially influencing dilution and capital structure for existing investors.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australian pharmaceutical company listed on the ASX that develops and commercialises health-related products. The company operates in the broader life sciences and healthcare sector and raises capital through equity placements to support its ongoing activities and strategic initiatives.
Average Trading Volume: 187,797
Technical Sentiment Signal: Sell
Current Market Cap: A$11.39M
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.